Top Companies' AI Moves
Sep 25, 2026

The Gist
IBM finds three in four employees say AI is dulling their critical thinking, while Bank of America plans to double its AI budget and Cisco reports most companies already run agentic AI. Dell argues that data access, not better models, will decide who wins, and Musk agrees with Dario Amodei that AI progress is slowing.
Today's Stories
- 1
IBM study: 3 out of 4 employees say AI erodes critical thinking
IBM's study found critical thinking is a top capability for an AI-enabled workplace, but 3 out of 4 employees say it and human judgment are beginning to erode due to AI. The erosion of critical thinking and human judgment is starting to show up as employees question the reliability of AI-driven decisions, which could slow adoption generally.
The stakes hinge on whether employers act on IBM's recommendations, such as rotations and supervised decision-making; watch for follow-up studies on younger employees' skills.
- 2
Enveda Biosciences raises $311 million in Series E
Enveda Biosciences raised $311 million in a Series E led by Catalio Capital Management, with 16 other backers including Surveyor Capital, T. Rowe Price and Lux Capital. The sum rivals totals secured in some of biotech's larger IPOs this year, and notably comes from private investors rather than the public markets.
Value hinges on whether Enveda's partnered drug candidates deliver clinical validation; its ENV-294 eczema and asthma Phase 2 trials are underway.
- 3
BofA's Moynihan: AI budget to double next year
Bank of America CEO Brian Moynihan said the bank expects to double its AI expense budget next year, after about 140 uses cost $400 million and generated $800 million in benefits. Doubling the budget signals the bank sees measurable returns from its current deployments, not just experimentation. Whether that spending continues depends on those returns holding up.
The test is whether the bank expands autonomy for AI agents—BofA's Hari Gopalkrishnan said it won't move until appropriate guardrails are in place.
- 4
Musk says "Dario is right" on AI slowdown
Anthropic CEO Dario Amodei wrote an essay urging companies to "slow the pace" of AI development, and Musk replied "Dario is right" on X on September 12, 2026. Musk has warned AI is the "biggest existential threat" to humanity, so his agreement signals alignment with the safety-first camp — though he separately said government regulation may not be the answer.
The slowdown is unlikely to be real, since SpaceX spent $23.5 billion on AI capital expenditures in the first half of this year, nearly 83% of its total spending. Whether the endorsement changes anything hinges on the gap between road-map ambition and actual output.
- 5
Dell: data access, not models, decides AI wins
Dell SVP Varun Chhabra told theCUBE customers want modular AI solutions spanning compute, storage, networking and GPU, while Dell CTO John Roese said the data layer 'is not magic' and must actually be built. A Dell-commissioned Omdia study found 79% of organizations have already experienced an AI-related incident in the past 12 months. If nearly four in five organizations have already hit an AI-related incident, the barrier to production AI looks less like model quality and more like whether the underlying data can be accessed and controlled, which is where Dell is positioning its pitch.
The outcome hinges on whether enterprises actually build that foundation rather than treat it as an add-on; a Dell-commissioned IDC study found 52% of government respondents plan to invest in sovereign AI within 12–18 months, a signal of where budgets may go.
- 6
51% run agentic AI; 84% eye AI-led ops in a year: Cisco
Cisco released an Omdia survey of 1,000 IT and network operations leaders showing 51% already run agentic AI in production and 84% expect an AI-led operating model within twelve months. With 75% having deployed AI for NetOps and 82% comfortable letting AI make some production network changes without prior human approval, the shift toward AI-led operations appears to be well underway.
The survey reports comfort with autonomy, not proven production outcomes, so the real test is whether operators can maintain control as autonomy grows.
What to Watch
Watch whether employers actually adopt IBM’s recommended rotations and supervised decision-making, and whether follow-up studies show real gains for younger employees. Also keep an eye on Enveda’s partnered drug candidates, especially the ENV-294 Phase 2 trials in eczema and asthma; if those deliver clinical validation, the value case becomes much stronger.
Sources
- IBM report warns AI could erode human skills deemed vital by CHROs
- Enveda, an AI drugmaker, banks $311M in venture funding
- Bank of America plans to double AI budget next year
- Elon Musk Just Said "Dario Is Right" About Slowing AI Development. Here's What That Endorsement Could Mean for Tesla's and xAI's AI Road Maps
- Data access drives enterprise AI success with Dell platform
- Cisco AI Research: AgenticOps Scaling Quickly in the Enterprise
- Closing the Gap Between AI Investment and Financial Return
- ‘Wonka’s the Golden Ticket’ resurrects Gene Wilder’s voice with AI. The result is lifeless
- Micron vs. Sandisk: Which AI Memory Stock Has More Room to Run?
- Fans slam ‘repulsive’ AI recreation of dead actor in new Netflix show
- Amazon rolls out new agentic AI for third-party sellers
- Starting to get more concerned about AI capex cycle, says Wells Fargo's Ohsung Kwon
- Micron’s stock has become a ‘battleground’ as the AI narrative shifts
- What's New in Oracle AI Agent Memory: Graph-Aware Retrieval, Image Memory, and Enterprise Controls
- Why the Biggest AI Opportunity Is Still Ahead
- Kroger Treads a Path to AI Led By Associates, Customer Experience
Share this with a friend
Send today's roundup to anyone who wants to keep up.
Get daily AI news free with AIToday
Today's AI, for Today's work. Email / LINE / Slack.
Sign up free